ARS Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRY and other ETFs, options, and stocks.About SPRY
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray.
CEORichard E. Lowenthal
CEORichard E. Lowenthal
Employees160
Employees160
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2015
Founded2015
Employees160
Employees160
SPRY Key Statistics
Market cap899.32M
Market cap899.32M
Price-Earnings ratio-17.78
Price-Earnings ratio-17.78
Dividend yield—
Dividend yield—
Average volume1.49M
Average volume1.49M
High today$9.10
High today$9.10
Low today$8.52
Low today$8.52
Open price$8.71
Open price$8.71
Volume943.38K
Volume943.38K
52 Week high$18.90
52 Week high$18.90
52 Week low$8.32
52 Week low$8.32
Stock Snapshot
As of today, ARS Pharmaceuticals(SPRY) shares are valued at $9.10. The company's market cap stands at 899.32M, with a P/E ratio of -17.78.
On 2025-11-05, ARS Pharmaceuticals(SPRY) stock traded between a low of $8.52 and a high of $9.10. Shares are currently priced at $9.10, which is +6.8% above the low and 0.0% below the high.
ARS Pharmaceuticals(SPRY) shares are trading with a volume of 943.38K, against a daily average of 1.49M.
In the last year, ARS Pharmaceuticals(SPRY) shares hit a 52-week high of $18.90 and a 52-week low of $8.32.
In the last year, ARS Pharmaceuticals(SPRY) shares hit a 52-week high of $18.90 and a 52-week low of $8.32.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SPRY. This list is generated using Robinhood data, and it’s not a recommendation.